NICE Guidelines

KardiaMobile for detecting atrial fibrillation - January 2022
NICE Medical Technologies Guidance (MTG33) - ENDURALIFE powered CRT-D devices for treating heart failure - July 2021 Originally published in March 2017, this revised guidance continues to recommend ENDURALIFE powered CRT-D devices. However, the costings have now been updated to reflect the lastest data. These data show the devices continue to be cost-effective.
NICE guideline (NG197) – Shared decision making: Key recommendations for healthcare professionals
NICE guideline - Shared decision-making (NG197) - June 2021
NICE AF guideline (NG196) - Key recommendations for primary care NICE AF guideline (NG196) - Key recommendations for secondary care NICE AF guideline (NG196) - Key recommendations for tertiary and specialist care
Atrial fibrillation: diagnosis and management - April 2021 Please note that NICE have amended the recommendation in the Atrial fibrillation guideline on using the ORBIT score to assess bleeding risk so that it links to a calculation tool that includes the full list of criteria, including reduced haemoglobin, reduced haematocrit and history of anaemia. The recommendation previously contained a link to a tool which didn’t include the full criteria.
Chronic Heart Failure: Management of chronic heart failure in adults in primary and secondary care (update) - March 2018
Surveillance report 2017 – Atrial fifibrillation: management (2014) NICE guideline CG180
New indicators to be added to the NICE indicator menu for general practice - August 2017
New indicators to be added to the NICE indicator menu for clinical commissioning groups -August 2017
Pulse rhythm assessment and annual review for people with AF - June 2017
Guide to the technology appraisal and highly specialised technologies appeal process- April 2017
ENDURALIFE-Powered CRT-D Devices for treating heart failure- March 2017
Zio Service for detecting cardiac arrhythmias- March 2017
Falls in older people QS86- March 2015
Bradycardia- dual chamber pacemakers- November 2014
Transient loss of consciousness ('blackouts') in over 16s- October 2014
Implantable cardioverter defifibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure- June 2014
Falls in older people: assessing risk and prevention CG161- June 2013
Insertion of a subcutaneous implantable cardioverter defifibrillator for prevention of sudden cardiac death- April 2013

Atrial Fibrillation 

Guide to the technology appraisal and highly specialised technologies appeal process- April 2017
AliveCor Heart Monitor and AliveECG app (Kardia Mobile) for detecting atrial fifibrillation
NICE Atrial Fibrillation Quality Standard- July 2015
NICE Atrial Fribrillation: QS93- July 2015
NICE publish update on AF management: CG180- June 2014 Read response from our sister charity AF Association

 

NICE Guidelines- Anticoagulants

Edoxaban for preventing stroke and systemic embolism in people with nonvalvularatrial fifibrillation- September 2015
Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fifibrillation- February 2013
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fifibrillation- May 2012
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fifibrillation- March 2012

NICE quality standards

NICE quality standards are a concise set of prioritised statements designed to drive measurable quality improvements within a particular area of health or care. They are derived from high quality guidance such as that from NICE or other sources accredited by NICE.
 

Click here to learn more about NICE quality standards.
 

Download our NICE information sheet | Visit NICE website

Guidance

View guidance relating to cardiac arrhythmias
 

September 2014: Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor) (DG14)

June 2014: Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120)

Read our response
 

News updates

NICE value the contribution that members of the public make to their guidance and quality standards. If you would like to consider becoming a representative, please view the current opportunities:

View opportunities

 

Please visit the NICE website to view further news updates. Click here.

 

International Guidelines for Active Standing Test Procedure

STANDARDS FOR LEAD EXTRACTION - A consensus document from UK lead extractors

ESC Guidelines

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
2018 ESC Guidelines for the diagnosis and management of syncope
2017 ESC/EACTS Guidelines for the management of valvular heart disease
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
2013 ESCGuidelines on cardiac pacing and cardiac resynchronization therapy
2010 Focused Update of ESC Guidelines on device therapy in heart failure
Guidelines for the diagnosis and management of syncope (version 2009)
ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias

ACC Guidelines

Guideline for the Evaluation and Management of Patients With Syncope 2017
Guideline for the Management of Adult Patients with SVT 2015
Guideline for the Management of Patients with AF 2014
Guideline on the Assessment of Cardiovascular Risk 2013
Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death 2006
Guidelines for the Management of Patients With Supraventricular Arrhythmias 2003

The Government’s mandate to NHS England for 2017-18
 

March 2017

The NHS has a unique place at the heart of our society and is – by some distance – the institution that makes us most proud to be British.
It is because of this that the 2017-18 mandate to NHS England goes further than ever before to ensure that we not only deliver the best care and support to today’s NHS patients, but also deliver the reform and renewal needed to sustain the NHS for the future.
Read more

 

New specialised commissioning consultation launched

October 2016

NHS England has today launched a consultation on four related policies that describe how NHS England will make decisions on funding for treatments that are not currently routinely commissioned. The four policies are: in-year service developments, individual funding requests, funding experimental and unproven treatments, and continuing funding after clinical trials.

Read more

A separate consultation  - https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-technology-appraisal-guidance/consultation-on-changes-to-technology-appraisals-and-highly-specialised-technologies  has also been launched today by NICE and NHS England jointly on changes to the arrangements for evaluating and funding drugs and other health technologies appraised through NICE’s Technology Appraisal (TA) and Highly Specialised Technologies (HST) programmes.